This federal contract award is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to the Veterans Integrated Service Network (VISN) 21, which is part of the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $65,000.00 and is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. The prime contractor is Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. that specializes in providing...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $170,415.00 and a period of performance through June 28, 2026. Cardinal Health 414, LLC is a major supplier of...
This federal contract award is for the delivery of RADIUM 223 XOFIGO, a radiopharmaceutical product, to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract has a potential value of $382,864.08 and is a firm fixed price delivery order with no set-aside designation. Cardinal Health 414 has provided...
This federal contract award, valued at $12,623.78, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy used to treat prostate cancer. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and related products to federal healthcare agencies including the VA, Department of Defense, and National...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $109,948.16 firm fixed price contract is for the delivery of the radiopharmaceutical product Xofigo Radium Ra 223 Dichloride. The contract, which has a completion date of March 31, 2021, was not set aside for any specific business type. Cardinal Health 414 holds several indefinite delivery vehicles (IDVs) to provide...
This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
This federal contract award to Cardinal Health 414, LLC was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $270,000.00 firm fixed price delivery order is for the radiopharmaceutical product Xofigo Radium 223. The contract has a completion date of February 1, 2019. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and has previously delivered radiopharmaceuticals, diagnostic imaging agents, and other...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy used for the treatment of prostate cancer. The contract has a ceiling value of $228,004.94 and a period of performance through February 28, 2025. Cardinal Health 414 is a...
This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC to manufacture and deliver Xofigo (radium-223), a radiopharmaceutical used for cancer treatment. The contract is a delivery order with a firm fixed price of $654,879.88 and a completion date of September 30, 2018. The contract does not have a set-aside designation. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical Xofigo, used in the treatment of prostate cancer. The contract has a potential value of $12,970.58 and a completion date of February 10, 2023. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and other...